[A clinico-biological study of the thrombocyte serotonin-transport complex in therapeutically resistant patients with endogenous depression undergoing combined treatment].
The platelet parameters of the functional status of the serotonin-reuptake complex were studied in drug-resistant depressive patients given various regimens of complex therapy or selective serotonin re-uptake inhibitors (fluvoxamine and fluoxetine). The most persistent and marked clinical effect was seen in electroconvulsive therapy and it was due to the normalization of the serotonin-reuptake system.
Brusov
O S
OS
Panteleeva
G P
GP
Bondar'
V V
VV
Dikaia
V I
VI
Faktor
M I
MI
Zlobina
G P
GP
Pavlova
O A
OA
Abrosimov
N V
NV
Lideman
R R
RR
D000328:Adult; D001692:Biological Transport; D001714:Bipolar Disorder / Q000097:blood / Q000628:therapy; D001792:Blood Platelets / Q000378:metabolism*; D003131:Combined Modality Therapy; D003866:Depressive Disorder / Q000097:blood* / Q000628:therapy; D004351:Drug Resistance; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D008297:Male; D012559:Schizophrenia / Q000097:blood / Q000628:therapy; D012701:Serotonin / Q000097:blood*
D012701:Serotonin
Kliniko-biologicheskoe issledovanie serotonintransportnogo kompleksa trombotsitov u terapevticheski rezistentnykh bol'nykh éndogennoĭ depressieĭ pri kompleksnom lechenii.